The first evidences of obesity-mediated pro-tumorigenic activity suggested the importance of altered systemic release of signaling molecules, including insulin, IGF-1, adipokines, cytokines and sexual hormones (Figure 1, Table 1). The gene discussed is INS; the disease is obesity disorder.